Abstract:To prepare mouse-original monoclon antibody against the product of vvhA gene encoding Vibrio vulnificus cytolysin and to identify its specificity and immunogenicity in order to lay a foundation for develment of a diagnostic kit to detect V. vulnificus,IPTG was used to induce the target recombinant protein rvvhA and Ni-NTA affinity chromatography was applied to extract rvvhA. By using SDS-PAGE plus BioRad Agarose Image Analysor, the effects of expression and purification of rvvhA were determined. The cell lines to secrete anti-rvvhA monoclonal antibodies were prepared and screened by hybridoma technique and rvvhA-ELISA, and then were cloned by limited dilution method. ELISA, immunodiffusion assay and Western blot hybridization were used to tetect the titers and specificity.Under induction with 0.5 mmol/L IPTG, the output of rvvhA could reach 18% of total bacterial proteins. The purified rvvhA only showed a single fragment in gel after SDS-PAGE. Nine cell lines of hybridoma were screened out, and lines A5E8 and C3B6 were found to be continuously secreting specific IgG1 or IgG2a monoclonal antibodies with high titers, respectively. This monoclonal antibodies showed high specificity,not reacting with the proteins from other bacteria.The titers in ELISA and immunodiffusion to rvvhA and the proteins from Vibrio vulnificus strains GTC333 and WZ01 were as high as 1∶4000∶1∶8000 and 1∶4-1∶8, respectively. The result of Western blot hybridization indicated that the monoclonal antibodies could recognize rvvhA efficiently. Two mouse-origin cell lines of hybridoma stably secreting specific monoclonal antibodies against rvvhA were obtained in this study. This anti-rvvhA monoclonal antibodies could be used to detect naturally secreted cytolysin of Vibrio vulnificus.

Preparation and Identification of Monoclonal Antibody Against Tumor-Associated Antigen OVA66

Preparation and Identification of Monoclonal Antibody Against Human Testis Development Related Gene 1

Preparation of a New Tumor Associated Antigen(ova66) and Its Preliminary Clinical Application

Preparation and characterization of a novel monoclonal antibody against human PD-1

[Preparation,Identification,and Application of Monoclonal Antibody against Orf Virus 118 Protein]

Tumorigenesis of NIH3T3 Cells Induced by the Exogenously Over-Expression of the Novel Tumor Antigen OVA66 (P2121)

[Identification of a Novel HLA-A2-restrictive CTL Epitope of an Ovary Cancer-Associated Antigen OVA66].

Preparation and Immunological Characterization of Monoclonal Antibody Against Ochratoxin A

Humoral Immune Responses Against Tumor‐associated Antigen OVA66 Originally Defined by Serological Analysis of Recombinant Cdna Expression Libraries and Its Potentiality in Cellular Immunity

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

Preparing and identifying a monoclonal antibody against human colorectal carcinoma

[Preparation and Characterization of Two Novel Functional Monoclonal Antibodies Against Human OX40L].

Preparation of Monoclonal Antibody Against Human Ospteopontin And Analysis of Its Specifity

Preparation of Anti-Human OX40 Agonist Monoclonal Antibody and Its Biological Function

Preparation Of Humanized Ovarian Carcinoma Anti-Idiotypic Minibody

Effects of the Over-Expression of Tumor Antigen Gene OVA66 on Biological Characteristics of WISH Cells

Synthesis and Identification of Ochratoxin A Artificial Immunogen

Construction,expression,and Identification of Ovarian Anti-Idiotypic Single Chain Antibody 6b11scfv and Mouse HSP70 Fusion Protein

Production and Characterization of Anti-OAS1 Monoclonal Antibody

Expression,purification and preparation of monoclonal antibody of HCA518 protein

Ova66, A Tumor Associated Protein, Induces Oncogenic Transformation Of Nih3t3 Cells